Quality Control – Ayurved Healing

HPLC Fingerprinting of Ayurvedic Formulations: Ensuring Quality Through Chromatographic Analysis

Dr. Meera Iyer — Sun, 09 Aug 2026 07:30:00 +0000

Why Your Triphala Might Not Be the Same as Mine

When two bottles carry the same Ayurvedic name, the label alone does not prove that they contain the same chemical profile. A Triphala Churna may be prepared from the right three fruits, yet differ because of fruit maturity, storage, geographic source, grinding, extraction, proportions, or substitution. Recent analytical work on commercial ashwagandha products has reported label-to-measured differences in withanolide and withanoside content ranging from about twofold to 35-fold, and analytical work on guggulu materials has reported wide variation in E- and Z-guggulsterones. For a practitioner or patient, this matters because “same name” should mean authenticated materials, consistent preparation, and reproducible quality.

High-performance liquid chromatography, or HPLC, fingerprinting is one of the most practical tools for closing that gap. Instead of treating an Ayurvedic formulation as a single molecule, it creates a multi-peak chemical portrait that can be compared across batches, suppliers, and reference preparations. Used alongside pharmacopoeial tests, microscopy, organoleptic evaluation, contaminant limits, and classical formulation discipline, it strengthens rather than replaces traditional quality assessment.

Understanding HPLC: The Basics

For readers without an analytical chemistry background, HPLC works on a straightforward principle. A liquid sample is pushed through a column packed with a stationary phase. Different compounds in the sample interact with the column material and mobile phase in different ways, so they leave the column at different times. As each compound exits, it passes through a detector that records its signal.

The output is a chromatogram: a graph showing detector response on the y-axis and time on the x-axis. Each peak represents a detectable compound or group of closely eluting compounds. The retention time helps identify a compound when compared with a reference standard under the same method conditions, and the peak area helps estimate how much of that compound is present. In complex preparations such as Triphala, Chyawanprash, or guggulu-based formulas, the value is not only in one peak but in the pattern of many peaks together.

HPLC Component	Function	Relevance to Ayurvedic Analysis
Pump	Delivers the mobile phase at controlled pressure and flow	Supports reproducible movement of the sample through the system for batch-to-batch comparison
Injector	Introduces a measured volume of prepared sample	Helps keep sample loading consistent for quantitative work
Column, often reverse-phase C18 for many herbal methods	Separates compounds according to chemical interaction with the stationary and mobile phases	Resolves complex plant extracts into a usable chromatographic pattern
UV-Vis or PDA Detector	Detects compounds that absorb light at selected wavelengths	Useful for tannins, phenolics, withanolides, guggulsterones, andrographolides, and many other plant constituents
Mass Spectrometer, when coupled to LC	Supports compound identification by mass-to-charge information	Helpful when unknown peaks, adulterants, or closely related compounds need deeper identification
Data Analysis Software	Processes chromatograms, integrates peaks, and compares profiles	Enables fingerprint comparison, marker quantification, and pattern recognition across batches

What HPLC Fingerprinting Reveals About Ayurvedic Products

HPLC fingerprinting is useful because it asks a question that a label cannot answer by itself: does this sample resemble an authenticated reference profile, and are the expected markers present in a plausible pattern? This is especially important for multi-herb preparations, where the therapeutic identity of the formula depends on the correct materials, proportions, and processing rather than on one isolated molecule.

Example 1: Triphala Churna

Triphala depends on the combined contribution of Haritaki, Bibhitaki, and Amalaki. Pharmacopoeial monographs describe these as fruit or fruit-pericarp drugs, and published chromatographic methods for Triphala commonly use tannin and phenolic markers such as gallic acid, ellagic acid, chebulagic acid, and chebulinic acid. A meaningful Triphala fingerprint should therefore assess the pattern created by all three fruits, not merely one marker such as gallic acid. Two samples may have a similar gallic acid value yet differ in the broader Terminalia and Emblica-derived profile.

Example 2: Ashwagandha Root Products

The Ayurvedic Pharmacopoeia describes Asvagandha as the dried mature root of Withania somnifera and gives alkaloids and withanolides among its constituents. For products sold as root powder or root extract, chromatographic profiling helps confirm whether the profile is consistent with root material and whether labeled withanolide-related claims match the measured sample. Because leaf and stem material can change the withanolide pattern, root identity should not be assumed only from the front label.

Example 3: Guggulu Preparations

Guggulu is the oleo-gum resin or exudate of Commiphora wightii. E- and Z-guggulsterones are important analytical markers, but they are not sufficient by themselves for full authentication. A broader guggulu fingerprint can include multiple triterpenoid, steroidal, and related resin markers so that genuine material can be distinguished from related resins or adulterants. In published HPLC fingerprint work, guggulsterone values varied widely across samples, and broader fingerprinting was used to detect adulteration that would not be solved by a single-marker test alone.

Building a Reference Fingerprint Library

For HPLC fingerprinting to become a dependable quality-control tool, a laboratory needs more than one “ideal” chromatogram. It needs a reference library built from authenticated materials, properly prepared batches, and defined natural variation. This is especially important in Ayurveda because plants are seasonal biological materials and because classical formulations depend on the right drug, part used, proportion, and method of preparation.

Authenticated raw materials: Reference batches should begin with botanically verified plant material, with plant part, source, collection details, and ideally voucher specimens recorded.
Pharmacopoeial anchoring: The Ayurvedic Pharmacopoeia of India provides official monograph standards for many single drugs and formulations, including identity, purity, extractive values, assay where applicable, and quality parameters.
Correct plant part: A root drug should be compared with root reference material, a fruit-pericarp drug with fruit-pericarp reference material, and an exudate or resin with the corresponding resin reference material.
Classical or formulary preparation: Where a formulation is described in an authoritative formulary or pharmacopoeial monograph, the composition and method should be followed and documented.
Multi-batch analysis: Multiple authenticated batches should be analyzed to define a realistic range for natural variation rather than forcing every natural product to match one rigid chromatogram.
Marker selection: Markers should include identity markers, proportion-sensitive markers, degradation markers where relevant, and adulteration-sensitive peaks rather than only the most famous constituent.
Safety and purity testing: Fingerprinting should be paired with limits for foreign matter, ash, extractives, microbial contamination, heavy metals, pesticide residues, aflatoxins, and other applicable quality parameters.

Marker Compounds and Classical Anchors for Key Ayurvedic Herbs

A good marker table should not invent universal “minimum active compound” cutoffs where none are established in the pharmacopoeial monograph. A better approach is to connect each herb to its authenticated Ayurvedic drug identity and then select analytical markers that help answer a specific quality question.

Herb	Ayurvedic / Pharmacopoeial Anchor	Practical HPLC / HPTLC Markers	Quality Question Answered
Amalaki Emblica officinalis / Phyllanthus emblica	Fruit pulp or dried fruit/pericarp drug; pharmacopoeial constituents include ascorbic acid and tannins	Ascorbic acid, gallic acid, ellagic acid, related hydrolysable tannins	Does the sample show the expected sour, tannin-rich fruit profile and contribute properly to Triphala?
Haritaki Terminalia chebula	Pericarp of mature fruit; pharmacopoeial constituents include tannins, anthraquinones, and polyphenolic compounds	Gallic acid, chebulagic acid, chebulinic acid, ellagic acid	Does the sample contain the expected Terminalia chebula pericarp profile?
Bibhitaki Terminalia bellirica / Terminalia belerica	Pericarp of dried ripe fruit; pharmacopoeial constituents include gallic acid, tannic acid, and glycosides	Gallic acid, tannic acid-related peaks, ellagic-type phenolics	Does the sample show the expected Bibhitaki contribution rather than an indistinct tannin signal?
Ashwagandha / Asvagandha Withania somnifera	Dried mature root; pharmacopoeial assay includes not less than 0.2% total alkaloids	Withanolide A, withaferin A, withanone, withanosides where the method is designed for them	Is the product consistent with root material, and do measured withanolide-related values match the label or internal specification?
Kalmegh Andrographis paniculata	Bitter Ayurvedic herb widely assessed through diterpene lactone markers	Andrographolide, neoandrographolide, deoxyandrographolide where included in the method	Does the sample contain the characteristic andrographolide-rich profile expected from good-quality Kalmegh?
Guggulu Commiphora wightii	Oleo-gum resin or exudate; identity cannot be secured by E- and Z-guggulsterones alone	E-guggulsterone, Z-guggulsterone, plus broader resin fingerprint markers	Does the resin profile support authentic Commiphora wightii and help detect related resin adulteration?

Beyond Single Markers: The Fingerprint Similarity Approach

Single markers are useful, but they are limited. Gallic acid may help evaluate Triphala, but it cannot by itself prove the correct balance of Haritaki, Bibhitaki, and Amalaki. E- and Z-guggulsterones may help evaluate guggulu, but they cannot by themselves prove full resin authenticity. The fingerprint approach compares the whole chromatographic pattern after suitable peak alignment, normalization, and method validation.

Similarity tools such as correlation analysis, cosine similarity, principal component analysis, and cluster analysis can compare a commercial batch against authenticated reference batches. The important point is that acceptance criteria must be developed for each formulation and method. A universal score is less meaningful than a validated method built from correct raw materials, repeated batches, and a realistic understanding of natural variation.

Practical Implications for Practitioners, Patients, and Researchers

HPLC fingerprinting is not only a laboratory concern. It changes how practitioners evaluate suppliers, how patients choose products, and how researchers design reproducible Ayurvedic studies.

For practitioners: Ask suppliers for a batch-specific certificate of analysis. A useful certificate should identify the botanical drug, plant part, batch number, testing date, pharmacopoeial parameters, contaminant testing, and chromatographic marker or fingerprint data where relevant.
For patients: Choose products from manufacturers that are transparent about testing and batch quality. Licensing and manufacturing standards are helpful baseline screens, but they do not replace batch-specific evidence. Very cheap products are not automatically poor, but extreme underpricing should invite careful scrutiny.
For researchers: Report the exact product, batch number, supplier, plant part, extraction method, marker compounds, and chromatographic profile of the test material. A clinical or experimental paper on “Triphala” or “Ashwagandha” is far more reproducible when the tested material is chemically characterized.

The Path Forward: Integrating Quality Science with Traditional Knowledge

HPLC fingerprinting is not about reducing Ayurveda to a collection of isolated molecules. It is about protecting the integrity of the materials named in Ayurvedic practice. Classical formularies prescribe specific substances in specific combinations and processes. If a modern product uses the wrong plant part, substitutes a related species, degrades in storage, or varies sharply from batch to batch, the problem is not merely chemical; it is a departure from the identity of the Ayurvedic preparation itself.

The best path forward is layered quality control: authenticated botanicals, correct plant part, pharmacopoeial identity and purity tests, contaminant testing, validated HPLC or HPTLC markers, and full fingerprint comparison for complex formulas. For a related discussion on how carrier substances affect the use of herbs, see The Science of Anupana. For a related discussion on Triphala’s complex phytochemical and gut-focused context, see How Triphala Reshapes Your Gut.

Medical Disclaimer: This article is for educational purposes only and does not diagnose, treat, cure, or prevent disease. Product selection, dose, herb-drug interaction questions, and therapeutic use should be discussed with a qualified Ayurvedic practitioner or licensed healthcare provider, especially during pregnancy, when managing a medical condition, or when taking prescription medicines.

References

Heavy Metal Content in Bhasma Preparations: Safety Data from ICP-MS Analytical Studies

Dr. Meera Iyer — Sat, 01 Aug 2026 06:00:00 +0000

Heavy Metal Content in Bhasma Preparations: Safety Data from Modern Analytical Studies

Few topics in Ayurvedic medicine generate as much controversy as bhasma preparations. These calcined metal, mineral, and animal-origin preparations belong to the Rasa Shastra tradition and have a long clinical history, yet they also sit at the center of legitimate safety concerns about lead, mercury, arsenic, and other toxic elements in Ayurvedic products.

A careful reading is more useful than either blanket fear or blanket reassurance. Properly manufactured bhasma is not the same as accidental heavy-metal contamination in an herbal capsule, because its intended material, processing, particle size, and chemical form all matter. At the same time, laboratory testing has repeatedly found unsafe metals in some commercial Ayurvedic products, especially products bought from unverified sources. Safety depends on identity, classical processing, chemical speciation, batch testing, dose, duration, and medical supervision.

What Are Bhasma Preparations?

Bhasma means an ash-like calcined product. In Rasa Shastra pharmaceutics, a metal, mineral, shell, pearl, coral, or related material is processed through purification and incineration stages known broadly as shodhana and marana. The material may be triturated with herbal juices or decoctions, made into pellets, sealed in earthen containers, and repeatedly heated. The intended result is a fine, lusterless, stable preparation rather than crude metal powder.

Classical and pharmaceutic quality checks are used to judge whether incineration has reached the expected endpoint. Modern laboratories add elemental analysis and structural analysis to these traditional tests, because the same named bhasma can vary by raw material, heating method, number of calcination cycles, and manufacturer.

Classical Test	Sanskrit Name	Practical Meaning	Modern Quality Concern Addressed
Lusterlessness	Nishchandratva	No visible metallic shine remains.	Helps screen for unprocessed free metal particles.
Fineness	Rekhapurnatva	The powder enters fine lines of the fingers when rubbed.	Indicates high fineness and reduction of coarse particles.
Floatability	Varitaratva	A small quantity floats on still water.	Reflects lightness and fine powder behavior.
Irreversibility	Apunarbhavatva	The material should not revert to its original metallic state after further heating with specified media.	Addresses incomplete conversion of the starting metal.
Non-reducibility	Niruttha	The product should not transfer metal to silver in the classical test.	Another screen for residual free metal.
Tastelessness	Niswadutva	The product should not have a sharp metallic taste.	Helps identify incomplete processing in some preparations.

What Modern Analysis Adds

Modern testing separates several questions that are often mixed together: how much of an element is present, what chemical compound it is present as, what particle size and morphology it has, whether toxic impurities are present, and how much enters systemic circulation. ICP-MS, ICP-OES, ICP-AES, X-ray fluorescence, X-ray diffraction, scanning electron microscopy, transmission electron microscopy, and related methods each answer different parts of that safety question.

Total metal content alone is not enough to judge a genuine metal-based bhasma, because a gold, iron, copper, zinc, tin, lead, or mercury preparation will naturally contain the intended element. For safety, total elemental analysis must be read together with chemical form, solubility, particle size, dose, duration, patient factors, and batch purity. For herbal-only products, however, lead, mercury, arsenic, and cadmium are contaminants unless clearly declared and justified by the formulation.

Swarna Bhasma: Gold Content, Particle Form, and Absorption

Swarna Bhasma is one of the most discussed bhasma preparations because gold is a noble metal and the prescribed doses are small. Published characterization work has reported gold as the major phase in prepared samples, but the percentage and particle dimensions vary across preparations and methods.

In one pharmaceutical standardization study, Swarna Bhasma prepared through a traditional method passed selected bhasma tests such as varitaratva, rekhapurnatva, and expected color. The finished product contained 52.33% gold by ICP-OES, with lead and cadmium below detection limits in that batch, while arsenic and mercury were detected. The same report also recorded particle sizes in the 1–10 µm range by spot magnification, showing that not every finished product can be described simply as a uniform nanoparticle preparation.

A human pilot bioavailability assessment administered Swarnabhasma in three regimens and measured blood gold using ICP-MS. Gold was detected only in trace amounts after a single dose. This supports cautious dosing and supervision rather than casual long-term self-use, because trace absorption does not remove the need for product identity and contaminant testing.

Tamra Bhasma: Copper Form Is Central to Safety

Tamra Bhasma requires special caution because copper in inappropriate form or excessive dose can cause gastrointestinal and systemic toxicity. The Ayurvedic safety logic is that copper must be purified, repeatedly processed, and converted into a stable bhasma that passes classical endpoint tests.

A quality-control study of Tamra Bhasma prepared from copper wire applied shodhana, marana, and amritikarana, then evaluated the final product using classical tests and modern tools. The final product passed tests such as rekhapurnatva and varitaratva. XRD showed prominent peaks of cupric sulfide, SEM showed particles below 2 µm, particle-size distribution gave a volumetric mean diameter of 28.70 µm, and ICP-AES measured 56.42% copper with 23.06% sulfur. Arsenic, lead, and mercury were present only in traces in that sample, while cadmium and selenium were not detected.

These details are important because they correct an oversimplified claim often made in discussions of Tamra Bhasma: a named bhasma cannot be assumed to be only one oxide form, nor can safety be inferred from name alone. The batch must be tested.

Lauha Bhasma and Yashada Bhasma: Iron and Zinc Preparations

Lauha Bhasma and Yashada Bhasma are often discussed as lower-concern metal bhasma when properly manufactured, because iron and zinc are essential elements. That does not mean they are risk-free. Excess iron can accumulate in susceptible patients, and zinc preparations can vary in chemical form and impurities.

Work on Lauha Bhasma preparation has described the importance of sequential purification and calcination in changing raw iron into a more processed iron-based material. Structural investigation of medicinal-grade Lauha Bhasma reported conversion of metallic iron into iron-oxide mineral phases, with magnetite microparticles appearing as agglomerates of nanoparticles. Yashada Bhasma analyses have reported zinc oxide or zinc sulfide phases depending on the processing method, with ICP-based elemental profiling used to assess trace elements and heavy metals.

The JAMA Internet-Product Survey: What It Really Means

The widely cited JAMA survey of Ayurvedic medicines sold via the internet remains highly relevant for public safety. It purchased 230 products, received and analyzed 193, and found detectable lead, mercury, or arsenic in 20.7% of products. Rasa Shastra products had a higher prevalence of detectable metals than non-Rasa Shastra products, and all metal-containing products exceeded at least one standard for acceptable daily intake of toxic metals.

The survey should be read as a serious product-quality warning. It tested commercial products bought online, not carefully supervised individualized prescribing from a qualified practitioner. It also measured metal concentrations rather than clinical pharmacokinetics or chemical speciation. Still, its practical message is unavoidable: consumers cannot assume an Ayurvedic label, an online listing, or a stated GMP claim guarantees safety.

Total Metal, Chemical Form, and Bioavailability

Total metal content answers only one part of the safety question. Iron oxide, elemental iron, soluble iron salts, and iron bound in hemoglobin all contain iron but behave differently in the body. The same principle applies to copper, zinc, mercury, lead, and arsenic: chemical form and solubility matter.

Mercury illustrates the point clearly. Cinnabar and mercuric sulfide are poorly absorbed from the gastrointestinal tract compared with methylmercury and more soluble mercury salts. This distinction is chemically meaningful, but it is not a license for self-medication with mercury-containing preparations. Poor absorption does not mean zero absorption, and cumulative exposure, impurities, overheating, wrong processing, wrong dose, and vulnerable patients can still create risk.

Preparation Type	Key Analytical Point	Safety Interpretation
Swarna Bhasma	Gold may be the major phase, but gold percentage, particle size, and trace elements differ by batch and method.	Requires identity testing and contaminant testing despite generally low systemic gold absorption in a small pilot study.
Tamra Bhasma	Published samples include sulfide forms and measurable trace contaminants.	Requires strict processing, low dose, short duration, and practitioner monitoring.
Lauha Bhasma	Processing changes raw iron into iron-oxide phases.	May be appropriate only when iron therapy is indicated; avoid unsupervised long-term use and consider ferritin status.
Yashada Bhasma	Different procedures may yield zinc oxide or zinc sulfide phases with different trace-element profiles.	Requires batch testing and avoidance of unnecessary zinc exposure.
Naga Bhasma	Lead-based preparations can contain lead sulfide or other lead compounds depending on processing.	High-risk category; specialist-only use, strong justification, and modern monitoring are essential.
Mercury-containing preparations	Mercury sulfide is less absorbable than methylmercury, but exposure is not zero.	High-risk category; avoid self-use and restrict to expert supervision where legally and clinically appropriate.

Which Bhasma Carry Lower or Higher Concern?

A practical safety ranking should not claim that any bhasma is automatically safe. It should separate lower-concern mineral preparations from preparations that contain toxic metals or require especially narrow dosing discipline.

Lower Concern When Properly Manufactured

Some preparations are based mainly on calcium carbonate, silicate minerals, iron, or zinc. Their risk is usually driven by product purity, inappropriate indication, wrong dose, prolonged use, and patient susceptibility rather than by the inherent toxicity of lead or mercury.

Shankha Bhasma: A conch-shell preparation, mainly calcium-rich, traditionally used for acid-peptic and digestive indications.
Praval and Mukta preparations: Coral and pearl preparations are calcium-carbonate based but still require authenticity and contaminant checks.
Abhraka Bhasma: A mica-based silicate preparation requiring careful processing and batch standardization.
Lauha Bhasma: Iron-based; avoid unnecessary use in people with high ferritin, iron overload disorders, active infection concerns, or liver disease unless supervised.
Yashada Bhasma: Zinc-based; avoid combining with other zinc supplements unless clinically indicated.

Moderate Concern Requiring Active Monitoring

These preparations can be clinically important in traditional practice, but the margin for error is smaller. Their use should be individualized, time-limited, and supported by batch-level testing.

Tamra Bhasma: Copper-based; unsuitable for casual use, prolonged unsupervised courses, or patients with copper metabolism disorders.
Vanga Bhasma: Tin-based; requires reliable manufacturing and practitioner supervision.
Rajata Bhasma: Silver-based; chronic unnecessary exposure should be avoided.

High Concern and Specialist Use Only

Preparations containing lead, mercury, arsenic compounds, or closely related toxic mineral inputs require the highest safety threshold. They should never be treated as wellness supplements.

Naga Bhasma: Lead-based; lead exposure is a genuine toxicological concern even when processed.
Parada, Rasa Sindura, Makaradhwaja, and related mercury preparations: Require expert Rasa Shastra knowledge, legal compliance, contaminant testing, clear indication, limited duration, and monitoring.
Formulations containing arsenic minerals: Require exceptional caution and should not be used without specialist oversight.

Quality Control Recommendations for Practitioners and Patients

The safest approach combines classical Rasa Shastra standards with modern laboratory quality control. Neither system should be used as a substitute for the other.

Use qualified supervision only: Bhasma preparations should be prescribed by a qualified Ayurvedic practitioner trained in Rasa Shastra, not self-selected from online listings.
Demand batch-level testing: A certificate of analysis should identify the batch and include elemental testing for lead, mercury, arsenic, cadmium, and relevant intended metals.
Prefer transparent manufacturers: The label should show batch number, manufacturing license details, ingredients, expiry, dose guidance, and safety warnings.
Verify identity and classical quality: Classical tests such as nishchandratva, rekhapurnatva, and varitaratva remain useful screening tools when performed by trained practitioners.
Avoid casual online purchase: Products sold without practitioner oversight, batch documentation, or transparent testing carry avoidable risk.
Use the lowest appropriate dose for the shortest appropriate duration: This principle is especially important for copper-, lead-, mercury-, arsenic-, and silver-containing preparations.
Use modern monitoring when risk is higher: Depending on the preparation, consider baseline and follow-up blood lead level, mercury level, liver function, kidney function, complete blood count, ferritin, copper status, or zinc status.
Disclose all medicines: Patients should tell both Ayurvedic and conventional healthcare providers about bhasma use, especially before surgery, pregnancy planning, or treatment for liver, kidney, neurological, gastrointestinal, or hematologic disease.

The Nanoparticle Dimension

Many bhasma discussions now use the word nanoparticle, but this needs precision. Some preparations contain nanoscale crystallites, some contain agglomerates of nanoparticles, and some measured batches show micrometre-scale particles. Particle size depends on raw material, grinding, calcination cycles, analytical method, and whether the measurement captures primary particles or agglomerates.

Nanoscale features may influence dissolution, surface area, tissue interaction, and dose behavior. They also add modern safety questions, because nanoscale materials can behave differently from bulk materials. For bhasma safety, particle-size claims should come from batch-specific SEM, TEM, XRD, DLS, or comparable analysis, not from the word bhasma alone.

A Balanced Safety Position

The most defensible position is neither to reject all bhasma as poison nor to accept all bhasma as safe. Properly prepared and properly prescribed bhasma is a distinct pharmaceutic category within Ayurveda. Poorly prepared, adulterated, mislabeled, or casually purchased products can cause real harm.

Classical processing matters because incomplete incineration can leave unsuitable material.
Modern batch testing matters because classical tests cannot quantify lead, mercury, arsenic, cadmium, or unintended contaminants.
Chemical form matters because total elemental content does not equal absorbed toxic dose.
Patient selection matters because children, pregnant or breastfeeding patients, and people with liver, kidney, neurological, or metabolic disorders may have much higher risk.
Lead-, mercury-, and arsenic-containing preparations deserve the highest threshold of caution and should never be used as casual wellness supplements.

For a broader discussion of how carrier substances influence Ayurvedic administration, see The Science of Anupana.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Bhasma preparations should be used only under the supervision of a qualified Ayurvedic practitioner and, when appropriate, in coordination with a conventional healthcare provider. Do not self-medicate with mineral, metal, mercury, lead, arsenic, or herbo-mineral preparations. Seek medical care promptly if you develop abdominal pain, nausea, vomiting, constipation, metallic taste, fatigue, high blood pressure, tremor, neuropathy, confusion, anemia, kidney problems, or other symptoms suggestive of heavy-metal exposure. Children, pregnant or breastfeeding people, and patients with liver, kidney, neurological, or serious chronic illness should avoid bhasma unless a qualified specialist determines that use is appropriate and monitored.

References

Heavy Metals in Ayurvedic Products: Testing Standards and What Consumers Should Know

Dr. Meera Iyer — Wed, 08 Apr 2026 09:00:00 +0000

A 2008 analysis published in JAMA examined 193 Ayurvedic medicines purchased through the internet from manufacturers in the United States and India. Detectable lead, mercury, or arsenic was found in 20.7% of the products. Every metal-containing product exceeded at least one of the daily-intake standards used by the investigators, and several Indian-manufactured rasa shastra products could have supplied lead or mercury at hundreds to thousands of times the cited limits when taken according to their labels. These findings apply to the sampled products rather than to Ayurveda as a whole, but they establish a practical need for ingredient transparency, reliable manufacturing, and batch-specific contaminant testing.

A separate investigation involving users of Ayurvedic products in an Iowa community found that 46 of 115 participants had blood lead concentrations of at least 10 micrograms per decilitre. That value was the investigation’s case threshold, not the current CDC reference value. The CDC now uses 3.5 micrograms per decilitre to identify children with blood lead levels higher than most children’s levels, and it states that this reference value is not a toxicity threshold. No safe blood lead level has been identified for children.

The Two Pathways by Which Metals Enter Ayurvedic Products

Metals may enter an Ayurvedic medicine unintentionally as contaminants or may be deliberately included as named ingredients in a classical herbo-mineral formulation. These situations require different forms of assessment, but neither should be judged from packaging claims alone.

Unintentional Environmental or Manufacturing Contamination

Medicinal plants can acquire arsenic, cadmium, lead, mercury, and other elements from soil, irrigation water, atmospheric deposition, fertilisers, pesticides, storage containers, grinding equipment, or cross-contamination during manufacture. The World Health Organization’s quality-control manual identifies environmental pollution and agricultural practices as possible sources of arsenic and heavy metals in medicinal plant materials. Similar contamination can affect botanical products from any medical tradition.

A 2018 public-health investigation analysed 252 Ayurvedic samples obtained during the investigation of a lead-poisoning cluster. Lead was detected in 65% of those samples, mercury in 38%, and arsenic in 32%. Because the samples were collected in a cluster investigation rather than through random market sampling, those percentages should not be treated as prevalence estimates for all Ayurvedic medicines. They do demonstrate that contaminated and intentionally metal-containing products can occur together within a supply chain.

Intentional Inclusion in Rasa Shastra Formulations

Rasa shastra is the Ayurvedic pharmaceutical discipline in which specified herbs may be combined with processed metals, minerals, salts, or gems. Preparations known as bhasmas are produced through procedures that may include shodhana or preparatory processing, wet trituration with prescribed media known as bhavana, and controlled heating or calcination known as marana. The ingredients and processing sequence differ according to the substance and formula; there is no single cycle count, temperature schedule, or processing medium applicable to every bhasma.

Classical and contemporary formulations may include processed gold (Swarna or Suvarna Bhasma), silver (Rajata Bhasma), iron (Lauha Bhasma), copper (Tamra Bhasma), tin (Vanga Bhasma), lead (Naga Bhasma), mica (Abhraka Bhasma), mercury-containing ingredients such as Parada or Hingula, and arsenic-containing substances such as Hartala and Manahshila. These are not interchangeable with ordinary herbal powders and should not be used without appropriate professional supervision and dependable pharmaceutical quality control.

What Product Surveys Have Established

The 2008 internet-market study distinguished products marketed as rasa shastra medicines from products described as non-rasa-shastra medicines. Detectable lead, mercury, or arsenic occurred in 40.6% of the rasa-shastra products and 17.1% of the others. The rasa-shastra products were therefore about 2.4 times, rather than six times, as likely to contain one or more of the measured elements.

The presence of an element does not by itself establish its source, chemical form, absorption, or clinical effect. Nevertheless, total concentration and the labelled daily dose are essential safety measurements. A product that supplies an excessive daily quantity of lead, mercury, arsenic, or cadmium remains a concern regardless of whether the element entered through soil, manufacturing equipment, substitution, cross-contamination, or deliberate formulation.

Documented poisonings have been associated with Ayurvedic products containing excessive concentrations of toxic elements. Public-health agencies in the United States and Australia have continued to issue warnings about specific imported or unapproved products containing lead, mercury, arsenic, and, in some cases, other undeclared toxic substances. Consumers should act on a warning for the named product and batch rather than assuming that country of origin, price, a “natural” claim, or traditional terminology guarantees quality.

How Regulatory Frameworks Differ

Ayurvedic products may be regulated as medicines, traditional herbal medicines, dietary supplements, complementary medicines, or imported unapproved products, depending on the jurisdiction and the claims made for them. The practical question is not merely whether a country has a numerical metal limit, but which legal category applies to the specific product and what evidence was reviewed before sale.

Jurisdiction	Relevant Framework	What a Consumer Can Check	Important Limitation
United States	Most orally consumed Ayurvedic supplements are sold under the dietary-supplement framework and must comply with applicable FDA labelling and 21 CFR Part 111 manufacturing requirements.	Full Supplement Facts panel, manufacturer identity, lot number, product-level USP or NSF certification, and a batch-specific laboratory report.	FDA generally does not approve dietary supplements before marketing. Facility registration or the phrase “FDA registered” is not product approval or certification.
India	Ayurvedic, Siddha, and Unani medicines are covered by Chapter IVA of the Drugs and Cosmetics Act and the applicable Drugs Rules. Schedule T specifies GMP requirements, while Rule 161 addresses ingredient labelling.	Manufacturer, manufacturing licence details, batch and expiry information, complete ingredients, dosage, required warnings, and a batch Certificate of Analysis.	A GMP licence concerns the manufacturing system; it does not by itself disclose the measured metal content of the purchased batch.
European Union	Herbal medicinal products may require marketing authorisation or traditional-use registration. EMA quality guidance addresses identity, contaminants, microbiology, pesticides, mycotoxins, and toxic metals.	National registration or authorisation details, approved leaflet, labelled composition, and manufacturer.	A food supplement is not evaluated through the same pathway as a registered herbal medicinal product.
United Kingdom	Eligible traditional herbal medicinal products may be registered through the MHRA Traditional Herbal Registration scheme.	A genuine THR number or authorised THR certification mark and the accompanying patient information.	THR confirms required standards for quality, safety, and traditional use; it does not mean that effectiveness was assessed to the standard required for a conventional marketing authorisation.
Australia	Complementary medicines supplied legally are generally entered in the Australian Register of Therapeutic Goods as listed, assessed-listed, or registered medicines.	An AUST L, AUST L(A), or AUST R number on the label and a corresponding ARTG entry.	Unregistered products obtained through overseas websites, personal importation, or informal sellers may fall outside the normal Australian supply controls.

Why a Single “Permissible ppm” Number Is Inadequate

Acceptable specifications depend on the product category, element, daily dose, route of administration, intended duration, applicable pharmacopoeia, and national law. Concentration expressed in parts per million or milligrams per kilogram must be considered together with the quantity consumed each day. Two products with the same concentration can produce different daily exposure when their recommended doses differ greatly.

The WHO manual on medicinal plant materials proposed maximum amounts of 10 milligrams per kilogram for lead and 0.3 milligrams per kilogram for cadmium in dried plant materials. It did not establish a universal four-element limit of 10 ppm lead, 1 ppm mercury, 3 ppm arsenic, and 0.3 ppm cadmium for every herbal medicine, dietary supplement, bhasma, and finished dosage form. A laboratory report should identify the specification used rather than merely stating “within WHO limits.”

Voluntary product-level programmes can provide additional assurance. The USP Verified programme evaluates identity, labelled strength or amount, contaminants such as heavy metals, manufacturing practices, and product performance. NSF/ANSI 173 certification likewise includes label-claim and contaminant requirements. These marks should be verified in the certifier’s current online directory because a facility-level GMP certificate is different from certification of a particular finished product.

Reading the Ingredient List for Metal and Mineral Components

Dosage form alone does not determine whether a product is herbal-only. A churna, vati, gutika, avaleha, asava, arishta, oil, capsule, or tablet may be herbal or may form part of a multi-ingredient preparation. The complete formula and source text or manufacturer’s specification must be examined.

Terms that warrant closer review include:

Bhasma, indicating a specifically processed ash or calcined material.
Parada, Hingula, Rasa Sindura, or related mercury-containing ingredients.
Naga, Vanga, Tamra, Lauha, Mandura, Yashada, Rajata, or Swarna/Suvarna when used as processed metal ingredients.
Hartala, Manahshila, or Gauripashana, which are arsenic-containing mineral substances.
Abhraka, Makshika, and other mineral ingredients requiring substance-specific processing and testing.

A single-herb powder or extract labelled only with a verified botanical species, plant part, and excipients has no declared herbo-metallic ingredient, but it can still contain environmental or manufacturing contaminants. Conversely, familiar formula names should not be classified as safe or hazardous solely from the name because compositions can differ among classical references, proprietary versions, and manufacturers.

How Bhasma Preparation and Testing Should Be Understood

Traditional bhasma manufacture is substance-specific. Processes described in rasa-shastra literature may use repeated purification, grinding, levigation with designated liquids, pellet formation, sealing, and controlled heating. Classical finishing examinations such as nischandratva, rekhapurnatva, varitara, apunarbhava, and niruttha assess characteristics such as absence of metallic lustre, fineness, floating behaviour, and resistance to reversion under specified conditions. They form part of traditional pharmaceutical assessment but do not replace contemporary chemical, microbiological, and toxicological controls.

Instrumental methods answer different questions. Inductively coupled plasma mass spectrometry or optical-emission spectrometry can quantify total elemental content. X-ray diffraction can help identify crystalline phases, while electron microscopy can describe particle size and morphology. Additional methods may be needed to examine chemical speciation, dissolution, bioaccessibility, organic contaminants, microbes, pesticides, and batch-to-batch consistency. A result from one technique should not be presented as proof that a product is nontoxic.

One published characterization reported globular gold-containing particles averaging approximately 56–57 nanometres in a particular Swarna Bhasma sample. Other bhasma analyses have reported different particle sizes, aggregates, and chemical phases. The measurement therefore describes the tested material, not every Swarna Bhasma or all bhasmas. The presence of nanoscale particles is an analytical characteristic rather than an independent guarantee of purity, therapeutic benefit, or safety.

A Practical Consumer Safety Checklist

A responsible purchase should be traceable from the labelled ingredients and lot number to the manufacturer and the results for that production batch. The following checks are more useful than broad claims such as “ancient,” “natural,” “organic,” “laboratory tested,” or “made in an FDA-registered facility.”

Read every ingredient: Confirm the botanical name, plant part, extract ratio where relevant, excipients, and every metal or mineral ingredient. Do not rely only on the front-label product name.
Match the product to its regulatory category: Check the manufacturing licence and required particulars in India, a THR registration in the United Kingdom, an ARTG number in Australia, or applicable dietary-supplement labelling in the United States.
Request a batch-specific Certificate of Analysis: The report should match the lot number and identify the laboratory, test date, method, reporting units, detection or quantification limits, numerical results, and specifications for lead, cadmium, arsenic, and mercury.
Prefer an accredited laboratory: Look for testing performed within the laboratory’s accredited scope, commonly under ISO/IEC 17025. A manufacturer-created summary containing only the word “pass” provides less information than the signed analytical report.
Distinguish product certification from factory certification: GMP is important, but it does not mean that every finished batch has independently passed every contaminant test. Confirm whether a USP or NSF mark applies to the exact product.
Use greater caution with herbo-mineral products: Do not self-prescribe products containing lead-, mercury-, or arsenic-derived ingredients. Obtain them only under the guidance of a qualified Ayurvedic practitioner who can assess the indication, dose, duration, contraindications, and source.
Protect children and pregnancy: Children, fetuses, and pregnant people require particular protection from lead exposure. Discuss all Ayurvedic medicines and supplements with the treating healthcare professional before use.
Keep traceability records: Retain the container, invoice, batch number, expiry date, photographs of the label, and remaining tablets or powder if an adverse event or exposure concern arises.
Check regulator alerts: Search the relevant national regulator’s current safety notices before purchasing an imported product, especially when the seller provides no verifiable manufacturer or batch information.

Quality Control for Herbal-Only Products

Absence of an intentional metal ingredient is only one aspect of botanical quality. Correct identity requires the proper genus, species, plant part, and, where relevant, macroscopic, microscopic, chemical, or chromatographic characteristics. Substitution with a related species, use of the wrong plant part, excessive foreign matter, poor storage, and degradation can change a product even when its metal results are acceptable.

A suitable quality programme may also address pesticides, microbial contamination, aflatoxins or other mycotoxins, residual solvents, foreign matter, and adulterants according to the product and manufacturing process. Consumers should therefore avoid treating a heavy-metal certificate as a complete certificate of safety. It is one important component of identity, purity, strength, and contamination control.

Safety Disclaimer: This article is for educational purposes and does not replace medical diagnosis or treatment. Consult a qualified Ayurvedic practitioner and an appropriate healthcare provider before using any bhasma or herbo-mineral preparation, and before giving an Ayurvedic medicine to a child or using one during pregnancy. Suspected exposure may require blood, urine, or other testing selected according to the element, chemical form, dose, and timing. Contact a healthcare professional or poison-control service promptly after a known high exposure or if abdominal pain, vomiting, weakness, confusion, numbness, tremor, or other neurological symptoms occur. Do not discontinue prescribed medical treatment without professional advice.

Actionable Tip: Select one Ayurvedic product you currently use and compare its lot number with its Certificate of Analysis. Confirm that the document reports actual numerical results for lead, cadmium, arsenic, and mercury, names the analytical method and laboratory, and states the specification applied. When the manufacturer cannot provide a traceable batch report, the ingredients are incomplete, or the product contains a metal or mineral that was not clearly disclosed at purchase, pause further use and seek advice from a qualified practitioner or healthcare provider.